BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1570157)

  • 1. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of the SH2 and SH3 domains of the lck tyrosine protein kinase.
    Reynolds PJ; Hurley TR; Sefton BM
    Oncogene; 1992 Oct; 7(10):1949-55. PubMed ID: 1408136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of tripartite chimeras between Src and Lck.
    Kashishian A; MacAuley A; Cooper JA
    Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of GAP and GAP-associated proteins in lymphoid and fibroblast cells expressing lck.
    Ellis C; Liu XQ; Anderson D; Abraham N; Veillette A; Pawson T
    Oncogene; 1991 Jun; 6(6):895-901. PubMed ID: 1906156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation.
    Choi YB; Kim CK; Yun Y
    J Immunol; 1999 Nov; 163(10):5242-9. PubMed ID: 10553045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lck SH2 phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the zeta-chain and IL-2 production.
    Lewis LA; Chung CD; Chen J; Parnes JR; Moran M; Patel VP; Miceli MC
    J Immunol; 1997 Sep; 159(5):2292-300. PubMed ID: 9278318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
    Dutartre H; Harris M; Olive D; Collette Y
    Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD45 with Lck and components of the Ras signalling pathway in pervanadate-treated mouse T-cell lines.
    Lee JM; Fournel M; Veillette A; Branton PE
    Oncogene; 1996 Jan; 12(2):253-63. PubMed ID: 8570203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
    Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site.
    Gervais FG; Chow LM; Lee JM; Branton PE; Veillette A
    Mol Cell Biol; 1993 Nov; 13(11):7112-21. PubMed ID: 8413300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation.
    Veillette A; Fournel M
    Oncogene; 1990 Oct; 5(10):1455-62. PubMed ID: 2250907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
    Yamaguchi H; Hendrickson WA
    Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.